Literature DB >> 19195540

Positron emission tomography/computed tomography: the current technology and applications.

Erik Mittra1, Andrew Quon.   

Abstract

Positron emission tomography (PET) and combined PET/CT provide powerful metabolic and anatomical information together in a single exam. This article reviews the fundamentals of PET physics, the state of the art and future directions in PET technology, and the current clinical applications of PET. The latter is quite diverse and includes oncology, cardiology, neurology, and infection and inflammation imaging, all with FDG as the tracer. Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19195540     DOI： 10.1016/j.rcl.2008.10.005

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN： 0033-8389            Impact factor:   2.303


  19 in total

1.  Digital PET/CT: a new intriguing chance for clinical nuclear medicine and personalized molecular imaging.

Authors:  Orazio Schillaci; Nicoletta Urbano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-11       Impact factor: 9.236

Review 2.  Molecular imaging: current status and emerging strategies.

Authors:  M A Pysz; S S Gambhir; J K Willmann
Journal:  Clin Radiol       Date:  2010-07       Impact factor: 2.350

3.  A flexible, multifaceted approach is needed in health technology assessment of PET.

Authors:  Issa J Dahabreh; Constantine Gatsonis
Journal:  J Nucl Med       Date:  2014-07-21       Impact factor: 10.057

4.  Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.

Authors:  Jang Yoo; Joon Young Choi; Kyu Taek Lee; Jin Seok Heo; Soo Bin Park; Seung Hwan Moon; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-06-19

5.  Evaluation of the endothelial function in hypertensive patients with 13N-ammonia PET.

Authors:  Erick Alexánderson; Rodrigo Jácome; Moisés Jiménez-Santos; Juan Manuel Ochoa; Edgar Romero; Marco Antonio Peña Cabral; Alejandro Ricalde; Fernando Iñarra; Aloha Meave; Graciela Alexánderson
Journal:  J Nucl Cardiol       Date:  2012-06-12       Impact factor: 5.952

Review 6.  New frontiers in neuroimaging applications to inborn errors of metabolism.

Authors:  Morgan J Prust; Andrea L Gropman; Natalie Hauser
Journal:  Mol Genet Metab       Date:  2011-06-30       Impact factor: 4.797

7.  Digital Microfluidics: A New Paradigm for Radiochemistry.

Authors:  Pei Yuin Keng; R Michael van Dam
Journal:  Mol Imaging       Date:  2015-12-05       Impact factor: 4.488

8.  Distinguishing imaging features between spinal hyperplastic hematopoietic bone marrow and bone metastasis.

Authors:  Y Shigematsu; T Hirai; K Kawanaka; S Shiraishi; M Yoshida; M Kitajima; H Uetani; M Azuma; Y Iryo; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-19       Impact factor: 3.825

9.  The role of PET-CT in patients with incidental gallbladder cancer.

Authors:  Jean M Butte; Francisca Redondo; Enrique Waugh; Manuel Meneses; Rossana Pruzzo; Hugo Parada; Horacio Amaral; Hernán A De La Fuente
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

10.  Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice.

Authors:  Feng Liang; Jie Cao; Wei-Ting Qin; Xu Wang; Xue-Feng Qiu; Bing-Wei Sun
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.